Investor Relations

Latest Financial Results

Q2 2021

Quarter Ended Jun 30, 2021

Latest 10-K

For Fiscal Year 2021

Download Latest 10k

Stock Information

Symbol

Nasdaq: ZIVO

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

ZIVO Bioscience, Inc is dedicated to the development and commercialization of nutritional compounds and bioactive molecules created by its proprietary algal strains. ZIVO is currently in pre-revenue status. The Company is a licensor of internally developed intellectual property in the form of proprietary algae cultures, extracts, derivatives, product and ingredient concepts.

The company is targeting the following applications:

  • Human Dietary Supplements & Nutraceuticals | Food Ingredients
  • Animal Feed, Dietary Supplements & Drug Development
  • Pharmaceuticals for Human Use

Investor Relations

CORE IR
T: 516-222-2560
investor@zivobioscience.com

Transfer Agent

Issuer Direct
1981 Murray Holladay Road
Suite 100
Salt Lake City, UT 84117
T: 801-272-9294
www.issuerdirect.com